Efficiency of combined endocrine therapy with CDK4/6 inhibitors in metastatic HR⁺/HER2^- breast cancer: Immunological aspects by A. V. Sultanbaev, I. A. Tuzankina, I. V. Kolyadina, A. F. Nasretdinov, Sh. I. Musin, N. I. Sultanbaeva, K. V. Menshikov, A. A. Izmailov, M. V. Sultanbaev, D. A. Kudlay

Subjects: “…hr⁺/her2^- breast cancer…”
Get full text